Table 4.
DCE: mean estimates | DCE: individual estimates | PTT | ||||
---|---|---|---|---|---|---|
Mean (SE) | 95% CI | Mean (SE) | 95% CI | Mean (SE) | 95% CI | |
MAR: 40% point RA risk reduction | ||||||
Chance of mild side effectsa | 50.8 (8.2) | 34.7;66.8 | 42.6 (23.1) | −2.7;87.8 | 18.1 (0.9) | 16.3;19.9 |
Chance of serious infection | 14.0 (1.6) | 10.9;17.1 | 20.6 (25.2) | −28.9;70.1 | 10.2 (0.7) | 8.9;11.6 |
Chance of serious side effectsa | 1.2 (0.4) | 0.5;2.0 | 2.2 (1.2) | −0.2;4.5 | 1.4 (0.3) | 0.8; 2.0 |
CI confidence interval, DCE discrete choice experiment, MAR maximum acceptable risk, PTT probabilistic threshold technique, SE standard error
aThese attributes were effects coded, linearity was assumed between levels and extrapolated beyond the levels included in the DCE for the purpose of the MAR calculation